Semiadaptive Infusion Control of Medications With Excitatory Dose-Dependent Effects. - Junxi Zhu; Xin Jin; Ramin Bighamian; Chang-Sei Kim; Steven T. Shipley; Jin-Oh Hahn (IEEE Trans. Control. Syst. Technol., 2019)

Design and Actuator Optimization of Lightweight and Compliant Knee Exoskeleton for Mobility Assistance of Children with Crouch Gait. - Sainan Zhang; Tzu-Hao Huang; Chunhai Jiao; Mhairi MacLean; Junxi Zhu; Shuangyue Yu; Hao Su (CoRR, 2021)

Medical Robots for Infectious Diseases: Lessons and Challenges from the COVID-19 Pandemic. - Antonio Di Lallo; Robin Roberson Murphy; Axel Krieger; Junxi Zhu; Russell H. Taylor; Hao Su 002 (IEEE Robotics Autom. Mag., 2021)

Tracking the Adaptation and Compensation Processes of Patients' Brain Arterial Network to an Evolving Glioblastoma. - Junxi Zhu; Spencer Teolis; Nadia Biassou; Amy Tabb; Pierre-Emmanuel Jabin; Orit Lavi (IEEE Trans. Pattern Anal. Mach. Intell., 2022)

Modeling and Stiffness-Based Continuous Torque Control of Lightweight Quasi-Direct-Drive Knee Exoskeletons for Versatile Walking Assistance. - Tzu-Hao Huang; Sainan Zhang; Shuangyue Yu; Mhairi MacLean; Junxi Zhu; Antonio Di Lallo; Chunhai Jiao; Thomas C. Bulea; Minghui Zheng; Hao Su 002 (IEEE Trans. Robotics, 2022)

Adaptive Hierarchical Origami Metastructures. - Yanbin Li; Antonio Di Lallo; Junxi Zhu; Yinding Chi; Hao Su 002; Jie Yin (CoRR, 2023)

Integrating Node Importance and Network Topological Properties for Link Prediction in Complex Network. - Junxi Zhu; Fang Dai; Fengqun Zhao; Wenyan Guo (Symmetry, 2023)

PGP: Prior-Guided Pretraining for Small-sample Esophageal Cancer Segmentation. - Qinglei Shi; Wenhan Duan; Wanyi Chen; Haotian Yang; Haochen Lu; Kecan Wu; Junxi Zhu; Juefei Yuan; Qiyan Ke; Andu Zhang; Xiang Wan; Changmiao Wang; et al. (BIBM, 2024)

Experiment-free exoskeleton assistance via learning in simulation. - Shuzhen Luo; Menghan Jiang; Sainan Zhang; Junxi Zhu; Shuangyue Yu; Israel Dominguez Silva; Tian Wang; Elliott J. Rouse; Bolei Zhou; Hyunwoo Yuk; Xianlian Zhou 001; Hao Su 002 (Nat., 2024)